Home » Topics » Regulatory » Patents

Patents
RSS

Voyager Therapeutics patents vector-based systems of augmenting protein destruction

Dec. 1, 2020

New EZH2 inhibitors synthesized at PharmaBlock Sciences

Nov. 30, 2020

Qilu Regor Therapeutics presents new CDK inhibitors

Nov. 30, 2020

New CD134 agonists identified at Bicycle Therapeutics

Nov. 30, 2020

Janssen discovers anti-HBV compounds

Nov. 30, 2020

University of Bern, Silence Therapeutics describe nucleic acids inhibiting PROS1

Nov. 30, 2020

Abmax Biopharmaceuticals TNF-alpha-targeting antibodies

Nov. 27, 2020

Chaser Therapeutics identifies new USP28 and USP25 inhibitors

Nov. 27, 2020

Idorsia Pharmaceuticals synthesizes new PDK1 inhibitors

Nov. 27, 2020

TYK Medicines divulges protein kinase inhibitors

Nov. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...